From Name:
From Email:
To Name:
To Email:

Optional Message:


FDA panel unanimously backs Novartis' psoriasis drug

from Reuters

An advisory panel to the U.S. Food and Drug Administration unanimously recommended the use of Novartis AG's anti-inflammation drug in patients with a type of psoriasis, paving the way for its approval. The panel voted 7-0 in favor of the drug's use in plaque-psoriasis, the most common form of the painful, unsightly skin condition. more


Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063